Signup to have metrics tracked for this article

By signing up, social media discussions about Response to letter to the editor on "Early benefit assessment of new drugs in Germany--results from 2011 to 2012" [Health Policy 116(2-3) (2014) 147-153]. will be collected and displayed on PubHawk. We'll also notify you by email on a monthly basis of any new updates captured on platforms like YouTube, Twitter/X, Bluesky, Facebook, LinkedIn, and more.
Your identifiable personal information will never be sold or shared to directly target you.

Please enter a valid email.
You must agree before submitting.

Example of Metrics tracking for this article:

Layout example
Response to letter to the editor on "Early benefit assessment of new drugs in Germany--results from 2011 to 2012" [Health Policy 116(2-3) (2014) 147-153].
Layout example